Literature DB >> 3310444

Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome.

H P Neumann.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3310444

Source DB:  PubMed          Journal:  Vasa        ISSN： 0301-1526            Impact factor:   1.961


× No keyword cloud information.
  23 in total

Review 1.  [Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions].

Authors:  N Bornfeld; K-M Kreusel
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

2.  Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.

Authors:  S Gläsker; B U Bender; T W Apel; V van Velthoven; L M Mulligan; J Zentner; H P Neumann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

Review 3.  [Retinal angiomatosis. Ocular manifestation of von Hippel-Lindau disease].

Authors:  B Junker; D Schmidt; H T Agostini
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

4.  Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.

Authors:  H Brauch; T Kishida; D Glavac; F Chen; F Pausch; H Höfler; F Latif; M I Lerman; B Zbar; H P Neumann
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

5.  Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.

Authors:  H J Decker; C Neuhaus; A Jauch; M Speicher; T Ried; M Bujard; H Brauch; S Störkel; M Stöckle; B Seliger; C Huber
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

6.  Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer.

Authors:  Aleksandra Tołoczko-Grabarek; Andrzej Sikorski; Marek Brzosko; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2005-08-15       Impact factor: 2.857

7.  Successful treatment of a haemangioblastoma in a 95 year-old patient. Case report.

Authors:  G Laborde; J Gilsbach; A Harders
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

8.  Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

Authors:  C Eng; P A Crossey; L M Mulligan; C S Healey; C Houghton; A Prowse; S L Chew; P L Dahia; J L O'Riordan; S P Toledo
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

9.  Cytogenetic studies on three pheochromocytomas derived from patients with von Hippel-Lindau syndrome.

Authors:  M Kiechle-Schwarz; H P Neumann; H J Decker; C Dietrich; B Wullich; W Schempp
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

10.  Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.

Authors:  Astrid Rasmussen; Elisa Alonso; Adriana Ochoa; Irene De Biase; Itziar Familiar; Petra Yescas; Ana-Luisa Sosa; Yaneth Rodríguez; Mireya Chávez; Marisol López-López; Sanjay I Bidichandani
Journal:  BMC Med Genet       Date:  2010-01-12       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.